BioCentury
ARTICLE | Company News

Paladin, ViRexx Medical infectious news

January 5, 2009 8:00 AM UTC

Paladin completed its previously announced acquisition of ViRexx. The acquisition occurred as part of an order for reorganization granted by the Court of Queen's Bench of Alberta (see BioCentury, Dec....